Analysis published 27 Mar 2026

AI-generated · cited to primary sources · not investment advice

Bharat Electron (500049) May 2023 Filing Analysis

01 · Management Credibility

Does management do what it says?

ExceededOther Findings
100/100

The company reported an EBITDA margin of 25.22% for FY 2023-24, surpassing the guided range of 21% to 23%. (5 exceeded across 5 tracked commitments)

We expect to maintain the EBITDA margin around 21% to 23%, in the coming year, ‘23, ’24, because there are different product mix, which are there.

Bharat Electron · Concall Transcript · May 2023 · p.6
MetSpace and Dual-Use Technology Convergence
85/100

The current non-defense mix is 14%, aligning closely with the long-term target of 15%. (1 met across 1 tracked commitment)

First, I will answer around 85/15 is the typical we are expecting this year. But it has been hovering around from 80/20 to 90/10 depending upon which year we get more civilian products

Bharat Electron · Concall Transcript · May 2023 · p.9
ExceededOrder Book to Revenue Ratio
76/100

BEL acquired its highest-ever order inflow of INR 35,000 crores in FY 2023-24, significantly exceeding the guidance of INR 20,000 crores plus. (2 exceeded, 3 in progress across 5 tracked commitments)

It will not be a problem because what order booking we are projecting in this financial year is INR20,000-plus crores, which is not factoring many big ticket programs which are in pipeline.

Bharat Electron · Concall Transcript · May 2023 · p.4
In progressExport Revenue as Percentage of Total
70/100

Management confirmed a target of USD 90 million for the year, having achieved approximately USD 10 million (INR 87 crores) in Q1. (3 in progress, 2 met across 5 tracked commitments)

This year we are targeting around $90 million to $100 million. We are participating in various programs, various discussions with customer, going as a part of government delegation also to make sure that we get significant export order.

Bharat Electron · Concall Transcript · May 2023 · p.20
ExceededLong Gestation R&D Investment
63/100

Management confirmed that R&D expenditure will continue to be around 6% to 7% of revenues for the current year. (2 in progress, 1 missed, 1 exceeded across 4 tracked commitments)

And this year likely, expenditure will be around INR700 crores to INR800 crores in capex.

Bharat Electron · Concall Transcript · May 2023 · p.7

See the full cited Management analysis of Bharat Electron

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.